Gevo, Inc. (NASDAQ:GEVO - Get Free Report)'s stock price rose 0.3% during trading on Wednesday . The stock traded as high as $1.81 and last traded at $1.76. Approximately 862,833 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 8,862,810 shares. The stock had previously closed at $1.75.
Analyst Ratings Changes
Several equities research analysts have recently weighed in on GEVO shares. HC Wainwright reissued a "buy" rating and issued a $14.00 target price on shares of Gevo in a research report on Wednesday, November 13th. UBS Group increased their price objective on shares of Gevo from $0.85 to $3.25 and gave the stock a "neutral" rating in a report on Tuesday, October 22nd.
Read Our Latest Research Report on GEVO
Gevo Price Performance
The business's fifty day moving average is $1.85 and its 200 day moving average is $1.53. The firm has a market capitalization of $421.36 million, a P/E ratio of -5.18 and a beta of 2.77. The company has a current ratio of 8.25, a quick ratio of 8.05 and a debt-to-equity ratio of 0.13.
Gevo (NASDAQ:GEVO - Get Free Report) last announced its earnings results on Thursday, November 7th. The energy company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.10) by $0.01. Gevo had a negative net margin of 510.04% and a negative return on equity of 14.95%. The company had revenue of $1.97 million for the quarter, compared to the consensus estimate of $6.08 million. During the same period in the previous year, the business earned ($0.07) EPS. As a group, analysts forecast that Gevo, Inc. will post -0.32 EPS for the current year.
Insiders Place Their Bets
In other Gevo news, insider Andrew Shafer sold 26,911 shares of the company's stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $2.37, for a total value of $63,779.07. Following the sale, the insider now directly owns 332,430 shares in the company, valued at $787,859.10. This represents a 7.49 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 4.00% of the company's stock.
Institutional Investors Weigh In On Gevo
A number of large investors have recently bought and sold shares of GEVO. Lauterbach Financial Advisors LLC acquired a new stake in shares of Gevo in the 3rd quarter valued at approximately $29,000. Signal Advisors Wealth LLC bought a new stake in shares of Gevo in the fourth quarter valued at about $34,000. Ballentine Partners LLC acquired a new position in shares of Gevo during the fourth quarter worth about $54,000. International Assets Investment Management LLC bought a new position in shares of Gevo during the fourth quarter worth about $59,000. Finally, Centerpoint Advisory Group bought a new stake in Gevo in the 4th quarter valued at approximately $75,000. 35.17% of the stock is currently owned by institutional investors.
About Gevo
(
Get Free Report)
Gevo, Inc operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein.
Recommended Stories
Before you consider Gevo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gevo wasn't on the list.
While Gevo currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
